Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-01
1996-09-17
Seidleck, James J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424659, 549361, A01N 4332
Patent
active
055568793
ABSTRACT:
Aqueous pharmaceutical compositions containing up to about 40% spectinomycin, prepared by the reaction of the ketone hydrate of spectinomycin with boric acid to form the boron compound, and with a base such as sodium hydroxide to form the stable salt of the compound.
REFERENCES:
"The Chemistry of Actinospectacin", Wiley, P. F., Argoudelis, A. D., Hoeksma, H. J., J. Am. Chem. Soc. 85, 2652, (1963).
"Stereochemistry and Absolute Configuration of the Antibiotic Spectinomycin", Cochran, T. G., Abraham, D. J., J.C.S. Chem. Comm. 495, (1972).
Hopponen Raymond E.
Macy Lowell R.
Mosley Terressa
Rhone Merieux, Inc.
Seidleck James J.
LandOfFree
Aqueous spectinomycin borate solutions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous spectinomycin borate solutions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous spectinomycin borate solutions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-413471